Sun Pharmaceutical Industries had received approval from US health regulator to market generic Clarinex tablets and Tiazac capsules, used in treating nasal allergies and hypertension, respectively, in the US market.

The firm has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) to market a generic version of Schering Plough’s Clarinex tablets.The company has received the approval for generic Clarinex tablets in the strength of 5mg. The tablets are indicated for allergic rhinitis or allergic inflammation of the nasal airways. Clarinex tablets (5mg) have annual sales of nearly $212 million in the US.

Allergic Rhinitis occurs when an allergen such as pollen or dust is inhaled by an individual with a sensitised immune system and triggers antibody production. In a separate statement, the company said it has received approval from USFDA for generic Tiazac capsules (Annual Sales of $ 12 m) used for treating high blood pressure.crackcrack

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×